Protecting the health and safety of trial participants is extremely important to us at Cromos Pharma. We exercise extreme diligence in our approach to site selection and to choosing Investigators. While most companies face challenges in subject recruitment and retention, Cromos Pharma consistently on track when it comes to achieving the “Last Patient In” target. Our key focus is on maintaining our extensive professional network, which has consistently delivered patients supportive of the clinical trial research process.
By analyzing study population, sites’ motivation to enroll, type of disease, subjects’ barriers to participation (e.g., travel distances, number of clinic visits, etc.), we have developed a proprietary algorithm that facilitates identification, recruitment, and retention of the precise type of patients needed for the successful trial conduct.
Finally, Cromos Pharma engages its feasibility team during the startup phase of each trial. By doing this, the knowledge gained during the feasibility process is shared and transferred efficiently to the clinical operations team. This ensures effective launch and subsequent conduct of every clinical program.
Cromos Pharma has over 18 years of experience in managing all aspects of clinical trials across a range of therapeutic areas. With operations in the US, Central and Eastern Europe we combine global expertise with profound local market knowledge to deliver end to end solutions supporting our pharma and biotech clients.